Inclusion | Exclusion |
• Males and females aged over 18 years • Females using a prescribed form of birth control (e.g., oral contraceptive) • Experiencing three or more of the following symptoms of gastrointestinal discomfort including bloating, flatulence, diarrhoea, constipation, reflux, heart burn, abdominal pain/discomfort experienced at least 3 days in the last month • Normal dietary habits (no FODMAP diet, elimination diet, vegan diet, etc) with a minimum 2-month period of self-reported dietary stability. • Agree to not change current diet or exercise regime during entire study period • Agree to not use any other dietary supplements or digestive enzymes during the study period • Able to provide informed consent
| • Unstable or serious illness (e.g., kidney, liver, GIT, heart conditions, diabetes, thyroid gland function Malignancy) • People with a past or current history of inflammatory bowel disease or gastrointestinal tract surgery • Pregnant or breastfeeding mothers • Malignancy or treatment for malignancy within the previous 2 years • Receiving/ prescribed coumadin (Warfarin), heparin, dalteparin, enoxaparin or other anticoagulation therapy including low dose aspirin • Active smokers, nicotine, alcohol, drug abuse • Chronic past and/or current alcohol use (>14 alcoholic drinks week) • Allergic to any of the ingredients in active or placebo formula • Any history of kiwi fruit allergy • Those suffering from insomnia or have night-shift employment and unable to have a normal night’s sleep • People suffering any neurological disorders such as MS • Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion (including hypercholesterolemia) • Participants who have participated in any other clinical trial during the past 3 months • Clinically significant acute or chronic inflammation, or connective tissue disease or arthritis • History of infection in the month prior to the study or taking antibiotic therapy • Hydration therapy during study period |